% Expired Patents = 50.0

Forward Citations = 2

Loading Chart...

6 inventors (with patents filed for the assignee):

Dale E Bredesen (4 out of 20 patents)

Shahrooz Rabizadeh (2 out of 86 patents)

Kayvan R Niazi (2 out of 101 patents)

4. Veronica Galvan (1 out of 2 patents)

5. Sabina Sperandio (1 out of 1 patent)

6. Susana Castro-Obregon (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 9789121 - Small molecules that replace or agonize p53 function (2017-10-17),

2. 7994184 - Small molecules that replace or agonize p53 function (2011-08-09),

3. 7544855 - Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664 (2009-06-09),

4. 6994981 - Modulators of paraptosis and related methods (2006-02-07),

Company Overview

The Buck Institute is a non-profit research organization dedicated to understanding the process of aging and improving human healthspan. Located in Novato, California, the institute focuses on researching the underlying mechanisms of age-related diseases such as cancer, Alzheimer's, and Parkinson's. Through collaborative research and partnerships with leading scientists, the Buck Institute is at the forefront of cutting-edge research in the field of aging.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#26 in Novato, CA

#14,051 in California

#60,641 in US

Novato, CA, United States of America

Buck Institute

Forward Citations = 2

6 inventors:

Dale E Bredesen (4 out of 20 patents)

Shahrooz Rabizadeh (2 out of 86 patents)

Kayvan R Niazi (2 out of 101 patents)

4. Veronica Galvan (1 out of 2 patents)

5. Sabina Sperandio (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Buck Institute. Retrieved from https://idiyas.com/company/buck-institute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]